Robert C. Rizzo

stony brook university

H指数:34

被引数:5,894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DOCKweb: a web-based GUI platform for molecular modeling with DOCK6

DOCKweb：一个基于Web的GUI平台，用于DOCK6分子建模

Journal of Computer-Aided Molecular Design

IF3.1

2026-07-060

PREAI

Expanding the Palette of Molecular Fragments for Small Molecule De Novo Design Through Isosteric Swapping

通过等电子替换扩展小分子从头设计中的分子片段调色板

Journal of Computational Chemistry

IF4.8

2026-01-130

PRE

Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2025-02-010

PRE

Development of Receptor Desolvation Scoring and Covalent Sampling in DOCK 6: Methods Evaluated on a RAS Test Set

DOCK 6中受体去溶剂化评分和共价采样的发展: 在RAS测试集上评估的方法

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2025-01-060

OAAI

Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor

FASEB JOURNAL

IF4.2

2024-11-160

PRE

Fragment and torsion biasing algorithms for construction of small organic molecules in proteins using DOCK

JOURNAL OF COMPUTATIONAL CHEMISTRY

IF4.8

2024-10-220

PRE

Rapid Rescoring and Refinement of Ligand-Receptor Complexes Using Replica Exchange Molecular Dynamics with a Monte Carlo Pose Reservoir

JOURNAL OF CHEMICAL THEORY AND COMPUTATION

IF5.5

2023-10-130

Descriptor-Driven de Novo Design Algorithms for DOCK6 Using RDKit

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2023-09-128

A molecular evolution algorithm for ligand design in DOCK

JOURNAL OF COMPUTATIONAL CHEMISTRY

IF4.8

2022-09-089

Inhibition of mutationally activated HER2

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2022-08-270

Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents

新型隐球菌的结构和抑制作用以开发抗真菌药物

NATURE COMMUNICATIONS

IF15.7

2021-10-0717

OAAI

Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2021-07-1644

OAAI

Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry

JOURNAL OF VIROLOGY

IF3.8

2019-08-0116

OAAI

FABP1 controls hepatic transport and biotransformation of Δ9-THC

SCIENTIFIC REPORTS

IF3.9

2019-05-2020

OAAI

SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins

特鲁西利酸单酯作为靶向脂肪酸结合蛋白的新型镇痛剂的SAR研究

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2018-06-0149

OAAI

Customizable De Novo Design Strategies for DOCK: Application to HIVgp41 and Other Therapeutic Targets

DOCK的可定制从头设计策略: 应用于HIVgp41和其他治疗靶标

JOURNAL OF COMPUTATIONAL CHEMISTRY

IF4.8

2017-09-2238

OAAI

Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity

通过足迹相似性鉴定E型肉毒杆菌神经毒素小分子抑制剂

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2016-10-0117

OAAI

Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A

肉毒杆菌神经毒素血清型A的新型抑制剂的计算机辅助鉴定，合成和生物学评估

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2015-09-0116

OAAI

DOCK 6: Impact of New Features and Current Docking Performance

JOURNAL OF COMPUTATIONAL CHEMISTRY

IF4.8

2015-04-27594

OAAI

Implementation of the Hungarian Algorithm to Account for Ligand Symmetry and Similarity in Structure-Based Design

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2014-01-2985

OAAI

Robert C. Rizzo

个人简介

教育背景

工作经历

荣誉奖项

研究方向